O	O	O	0	10	Activation	Activation	B-NP	NN	O	10	SUB	O
O	O	O	11	13	of	of	B-PP	IN	O	1	NMOD	O
T21	B-Entity	B-Entity	14	16	NF	NF	B-NP	NN	B-protein	6	NMOD	B-protein
T21	I-Entity	I-Entity	16	17	-	-	B-NP	HYPH	I-protein	6	NMOD	I-protein
T21	I-Entity	I-Entity	17	22	kappa	kappa	I-NP	NN	I-protein	6	NMOD	I-protein
T21	I-Entity	I-Entity	23	24	B	B	I-NP	NN	I-protein	2	PMOD	I-protein
O	O	O	25	27	by	by	B-PP	IN	O	1	NMOD	O
O	O	O	28	39	phosphatase	phosphatase	B-NP	NN	B-protein	9	NMOD	B-protein
O	O	O	40	50	inhibitors	inhibitor	I-NP	NNS	O	7	PMOD	O
O	O	O	51	59	involves	involve	B-VP	VBZ	O	0	ROOT	O
O	O	O	60	63	the	the	B-NP	DT	O	12	NMOD	O
O	O	O	64	79	phosphorylation	phosphorylation	I-NP	NN	O	23	NMOD	O
O	O	O	80	82	of	of	B-PP	IN	O	12	NMOD	O
T1	B-Protein	B-Protein	83	84	I	I	B-NP	NN	B-protein	17	NMOD	B-protein
T1	I-Protein	I-Protein	85	90	kappa	kappa	I-NP	NN	I-protein	17	NMOD	I-protein
T1	I-Protein	I-Protein	91	92	B	B	I-NP	NN	I-protein	17	NMOD	I-protein
T1	I-Protein	I-Protein	93	98	alpha	alpha	I-NP	NN	I-protein	13	PMOD	I-protein
O	O	O	99	101	at	at	B-PP	IN	O	12	NMOD	O
T22	B-Entity	B-Entity	102	113	phosphatase	phosphatase	B-NP	NN	B-protein	20	NMOD	B-protein
T22	I-Entity	I-Entity	114	116	2A	2A	I-NP	NN	I-protein	18	PMOD	I-protein
T22	I-Entity	I-Entity	116	117	-	-	B-NP	HYPH	O	23	NMOD	O
T22	I-Entity	I-Entity	117	126	sensitive	sensitive	I-NP	JJ	O	23	NMOD	O
T22	I-Entity	I-Entity	127	132	sites	site	I-NP	NNS	O	10	OBJ	O
O	O	O	132	133	.	.	O	.	O	10	P	O

O	O	O	135	145	Activation	Activation	B-NP	NN	O	11	SUB	O
O	O	O	146	148	of	of	B-PP	IN	O	1	NMOD	O
T23	B-Entity	B-Entity	149	151	NF	NF	B-NP	NN	B-protein	6	NMOD	B-protein
T23	I-Entity	I-Entity	151	152	-	-	B-NP	HYPH	I-protein	6	NMOD	I-protein
T23	I-Entity	I-Entity	152	157	kappa	kappa	I-NP	NN	I-protein	6	NMOD	I-protein
T23	I-Entity	I-Entity	158	159	B	B	I-NP	NN	I-protein	2	PMOD	I-protein
O	O	O	160	162	by	by	B-PP	IN	O	1	NMOD	O
O	O	O	163	170	various	various	B-NP	JJ	O	10	NMOD	O
O	O	O	171	179	cellular	cellular	I-NP	JJ	O	10	NMOD	O
O	O	O	180	187	stimuli	stimulus	I-NP	NNS	O	7	PMOD	O
O	O	O	188	196	involves	involve	B-VP	VBZ	O	0	ROOT	O
O	O	O	197	200	the	the	B-NP	DT	O	16	NMOD	O
O	O	O	201	216	phosphorylation	phosphorylation	I-NP	NN	O	16	NMOD	O
O	O	O	217	220	and	and	I-NP	CC	O	16	NMOD	O
O	O	O	221	231	subsequent	subsequent	I-NP	JJ	O	16	NMOD	O
O	O	O	232	243	degradation	degradation	I-NP	NN	O	11	OBJ	O
O	O	O	244	246	of	of	B-PP	IN	O	16	NMOD	O
O	O	O	247	250	its	its	B-NP	PRP$	O	19	NMOD	O
O	O	O	251	260	inhibitor	inhibitor	I-NP	NN	O	24	NMOD	O
O	O	O	260	261	,	,	O	,	O	24	P	O
T2	B-Protein	B-Protein	262	263	I	I	B-NP	NN	B-protein	24	NMOD	B-protein
T2	I-Protein	I-Protein	264	269	kappa	kappa	I-NP	NN	I-protein	24	NMOD	I-protein
T2	I-Protein	I-Protein	270	271	B	B	I-NP	NN	I-protein	24	NMOD	I-protein
T2	I-Protein	I-Protein	272	277	alpha	alpha	I-NP	NN	I-protein	17	PMOD	I-protein
O	O	O	277	278	,	,	O	,	O	11	P	O
O	O	O	279	287	although	although	B-SBAR	IN	O	11	VMOD	O
O	O	O	288	291	the	the	B-NP	DT	O	29	NMOD	O
O	O	O	292	302	underlying	underlie	I-NP	VBG	O	29	NMOD	O
O	O	O	303	312	mechanism	mechanism	I-NP	NN	O	30	SUB	O
O	O	O	313	320	remains	remain	B-VP	VBZ	O	26	SBAR	O
O	O	O	321	328	unclear	unclear	B-ADJP	JJ	O	30	PRD	O
O	O	O	328	329	.	.	O	.	O	11	P	O

O	O	O	330	332	In	In	B-PP	IN	O	22	VMOD	O
O	O	O	333	336	the	the	B-NP	DT	O	4	NMOD	O
O	O	O	337	344	present	present	I-NP	JJ	O	4	NMOD	O
O	O	O	345	350	study	study	I-NP	NN	O	1	PMOD	O
O	O	O	350	351	,	,	O	,	O	22	P	O
O	O	O	352	355	the	the	B-NP	DT	O	7	NMOD	O
O	O	O	356	360	role	role	I-NP	NN	O	22	SUB	O
O	O	O	361	363	of	of	B-PP	IN	O	7	NMOD	O
O	O	O	364	370	serine	serine	B-NP	NN	B-protein	12	NMOD	B-protein
O	O	O	370	371	/	/	B-NP	SYM	I-protein	12	NMOD	I-protein
O	O	O	371	380	threonine	threonine	I-NP	NN	I-protein	12	NMOD	I-protein
O	O	O	381	393	phosphatases	phosphatas	I-NP	NNS	I-protein	8	PMOD	I-protein
O	O	O	394	396	in	in	B-PP	IN	O	7	NMOD	O
O	O	O	397	400	the	the	B-NP	DT	O	15	NMOD	O
O	O	O	401	411	regulation	regulation	I-NP	NN	O	13	PMOD	O
O	O	O	412	414	of	of	B-PP	IN	O	15	NMOD	O
T3	B-Protein	B-Protein	415	416	I	I	B-NP	NN	B-protein	20	NMOD	B-protein
T3	I-Protein	I-Protein	417	422	kappa	kappa	I-NP	NN	I-protein	20	NMOD	I-protein
T3	I-Protein	I-Protein	423	424	B	B	I-NP	NN	I-protein	20	NMOD	I-protein
T3	I-Protein	I-Protein	425	430	alpha	alpha	I-NP	NN	I-protein	21	NMOD	I-protein
O	O	O	431	446	phosphorylation	phosphorylation	I-NP	NN	O	16	PMOD	O
O	O	O	447	450	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	451	463	investigated	investigate	I-VP	VBN	O	22	VC	O
O	O	O	463	464	.	.	O	.	O	22	P	O

O	O	O	465	468	Our	Our	B-NP	PRP$	O	2	NMOD	O
O	O	O	469	476	studies	study	I-NP	NNS	O	3	SUB	O
O	O	O	477	488	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT	O
O	O	O	489	493	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	O	494	504	incubation	incubation	B-NP	NN	O	48	SUB	O
O	O	O	505	507	of	of	B-PP	IN	O	5	NMOD	O
O	O	O	508	513	human	human	B-NP	JJ	B-cell_type	9	NMOD	B-cell_type
O	O	O	514	515	T	T	I-NP	NN	I-cell_type	9	NMOD	I-cell_type
O	O	O	516	521	cells	cell	I-NP	NNS	I-cell_type	6	PMOD	I-cell_type
O	O	O	522	526	with	with	B-PP	IN	O	5	NMOD	O
O	O	O	527	530	low	low	B-NP	JJ	O	12	NMOD	O
O	O	O	531	545	concentrations	concentration	I-NP	NNS	O	10	PMOD	O
O	O	O	546	547	(	(	O	(	O	19	DEP	O
O	O	O	547	560	approximately	approximately	B-NP	RB	O	18	NMOD	O
O	O	O	561	562	1	1	I-NP	CD	O	14	AMOD	O
O	O	O	562	563	-	-	I-NP	HYPH	O	14	AMOD	O
O	O	O	563	564	5	5	I-NP	CD	O	14	AMOD	O
O	O	O	565	567	nM	nM	I-NP	NN	O	19	DEP	O
O	O	O	567	568	)	)	O	)	O	12	NMOD	O
O	O	O	569	571	of	of	B-PP	IN	O	12	NMOD	O
O	O	O	572	581	calyculin	calyculin	B-NP	NN	O	22	NMOD	O
O	O	O	582	583	A	A	I-NP	NN	O	25	NMOD	O
O	O	O	584	586	or	or	O	CC	O	25	NMOD	O
O	O	O	587	594	okadaic	okadaic	B-NP	JJ	O	25	NMOD	O
O	O	O	595	599	acid	acid	I-NP	NN	O	28	NMOD	O
O	O	O	599	600	,	,	O	,	O	28	P	O
O	O	O	601	607	potent	potent	B-NP	JJ	O	28	NMOD	O
O	O	O	608	618	inhibitors	inhibitor	I-NP	NNS	O	20	PMOD	O
O	O	O	619	621	of	of	B-PP	IN	O	28	NMOD	O
O	O	O	622	629	protein	protein	B-NP	NN	O	32	NMOD	O
O	O	O	630	641	phosphatase	phosphatase	I-NP	NN	O	32	NMOD	O
O	O	O	642	646	type	type	I-NP	NN	O	41	NMOD	O
O	O	O	647	648	1	1	I-NP	CD	O	32	NMOD	O
O	O	O	649	650	(	(	O	(	O	38	DEP	O
O	O	O	650	652	PP	PP	B-NP	NN	B-protein	36	NMOD	B-protein
O	O	O	652	653	-	-	B-NP	HYPH	I-protein	38	DEP	I-protein
O	O	O	653	654	1	1	I-NP	CD	I-protein	36	NMOD	I-protein
O	O	O	654	655	)	)	O	)	O	32	NMOD	O
O	O	O	656	659	and	and	O	CC	O	41	NMOD	O
O	O	O	660	664	type	type	B-NP	NN	B-protein	41	NMOD	B-protein
O	O	O	665	667	2A	2A	I-NP	NN	I-protein	29	PMOD	I-protein
O	O	O	668	669	(	(	O	(	O	46	DEP	O
O	O	O	669	671	PP	PP	B-NP	NN	B-protein	45	NMOD	B-protein
O	O	O	671	672	-	-	B-NP	HYPH	I-protein	45	P	I-protein
O	O	O	672	674	2A	2A	I-NP	NN	I-protein	46	DEP	I-protein
O	O	O	674	675	)	)	O	)	O	41	NMOD	O
O	O	O	675	676	,	,	O	,	O	5	P	O
O	O	O	677	684	induces	induce	B-VP	VBZ	O	4	SBAR	O
O	O	O	685	688	the	the	B-NP	DT	O	50	NMOD	O
O	O	O	689	704	phosphorylation	phosphorylation	I-NP	NN	O	48	OBJ	O
O	O	O	705	707	of	of	B-PP	IN	O	50	NMOD	O
T4	B-Protein	B-Protein	708	709	I	I	B-NP	NN	B-protein	55	NMOD	B-protein
T4	I-Protein	I-Protein	710	715	kappa	kappa	I-NP	NN	I-protein	55	NMOD	I-protein
T4	I-Protein	I-Protein	716	717	B	B	I-NP	NN	I-protein	55	NMOD	I-protein
T4	I-Protein	I-Protein	718	723	alpha	alpha	I-NP	NN	I-protein	51	PMOD	I-protein
O	O	O	724	728	even	even	B-ADVP	RB	O	57	PMOD	O
O	O	O	729	731	in	in	B-PP	IN	O	48	VMOD	O
O	O	O	732	735	the	the	B-NP	DT	O	59	NMOD	O
O	O	O	736	743	absence	absence	I-NP	NN	O	57	PMOD	O
O	O	O	744	746	of	of	B-PP	IN	O	59	NMOD	O
O	O	O	747	750	any	any	B-NP	DT	O	63	NMOD	O
O	O	O	751	759	cellular	cellular	I-NP	JJ	O	63	NMOD	O
O	O	O	760	768	stimulus	stimulus	I-NP	NN	O	60	PMOD	O
O	O	O	768	769	.	.	O	.	O	3	P	O

O	O	O	770	774	This	This	B-NP	DT	O	2	NMOD	O
O	O	O	775	781	action	action	I-NP	NN	O	23	NMOD	O
O	O	O	782	784	of	of	B-PP	IN	O	2	NMOD	O
O	O	O	785	788	the	the	B-NP	DT	O	6	NMOD	O
O	O	O	789	800	phosphatase	phosphatase	I-NP	NN	O	6	NMOD	O
O	O	O	801	811	inhibitors	inhibitor	I-NP	NNS	O	3	PMOD	O
O	O	O	811	812	,	,	O	,	O	2	P	O
O	O	O	813	818	which	which	B-NP	WDT	O	2	NMOD	O
O	O	O	819	821	is	be	B-VP	VBZ	O	8	SBAR	O
O	O	O	822	832	associated	associate	I-VP	VBN	O	9	VC	O
O	O	O	833	837	with	with	B-PP	IN	O	10	VMOD	O
O	O	O	838	841	the	the	B-NP	DT	O	13	NMOD	O
O	O	O	842	852	activation	activation	I-NP	NN	O	11	PMOD	O
O	O	O	853	855	of	of	B-PP	IN	O	13	NMOD	O
O	O	O	856	859	the	the	B-NP	DT	O	16	NMOD	O
T5	B-Protein	B-Protein	860	864	RelA	RelA	I-NP	NN	B-protein	14	PMOD	B-protein
O	O	O	864	865	.	.	O	.	O	23	P	O
T6	B-Protein	B-Protein	865	868	p50	p50	B-NP	NN	B-protein	23	NMOD	B-protein
T24	B-Entity	B-Entity	869	871	NF	NF	I-NP	NN	I-protein	23	NMOD	I-protein
T24	I-Entity	I-Entity	871	872	-	-	B-NP	HYPH	I-protein	23	NMOD	I-protein
T24	I-Entity	I-Entity	872	877	kappa	kappa	I-NP	NN	I-protein	23	NMOD	I-protein
T24	I-Entity	I-Entity	878	879	B	B	I-NP	NN	I-protein	23	NMOD	I-protein
T24	I-Entity	I-Entity	880	891	heterodimer	heterodimer	I-NP	NN	I-protein	25	SUB	I-protein
O	O	O	891	892	,	,	O	,	O	23	P	O
O	O	O	893	895	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	896	899	not	not	I-VP	RB	O	25	VMOD	O
O	O	O	900	908	affected	affect	I-VP	VBN	O	25	VC	O
O	O	O	909	911	by	by	B-PP	IN	O	27	VMOD	O
O	O	O	912	918	agents	agent	B-NP	NNS	O	28	PMOD	O
O	O	O	919	923	that	that	B-NP	WDT	O	29	NMOD	O
O	O	O	924	929	block	block	B-VP	VBP	O	30	SBAR	O
O	O	O	930	933	the	the	B-NP	DT	O	33	NMOD	O
O	O	O	934	943	induction	induction	I-NP	NN	O	31	OBJ	O
O	O	O	944	946	of	of	B-PP	IN	O	33	NMOD	O
T7	B-Protein	B-Protein	947	948	I	I	B-NP	NN	B-protein	38	NMOD	B-protein
T7	I-Protein	I-Protein	949	954	kappa	kappa	I-NP	NN	I-protein	38	NMOD	I-protein
T7	I-Protein	I-Protein	955	956	B	B	I-NP	NN	I-protein	38	NMOD	I-protein
T7	I-Protein	I-Protein	957	962	alpha	alpha	I-NP	NN	I-protein	39	NMOD	I-protein
O	O	O	963	978	phosphorylation	phosphorylation	I-NP	NN	O	34	PMOD	O
O	O	O	979	981	by	by	B-PP	IN	O	31	VMOD	O
T8	B-Protein	B-Protein	982	987	tumor	tumor	B-NP	NN	B-protein	44	NMOD	B-protein
T8	I-Protein	I-Protein	988	996	necrosis	necrosis	I-NP	NN	I-protein	44	NMOD	I-protein
T8	I-Protein	I-Protein	997	1003	factor	factor	I-NP	NN	I-protein	44	NMOD	I-protein
T8	I-Protein	I-Protein	1004	1009	alpha	alpha	I-NP	NN	I-protein	40	PMOD	I-protein
O	O	O	1010	1011	(	(	O	(	O	49	DEP	O
T9	B-Protein	B-Protein	1011	1014	TNF	TNF	B-NP	NN	B-protein	48	NMOD	B-protein
T9	I-Protein	I-Protein	1014	1015	-	-	O	HYPH	I-protein	48	P	I-protein
T9	I-Protein	I-Protein	1015	1020	alpha	alpha	B-NP	SYM	I-protein	49	DEP	I-protein
O	O	O	1020	1021	)	)	O	)	O	44	NMOD	O
O	O	O	1021	1022	.	.	O	.	O	25	P	O

O	O	O	1023	1034	Furthermore	Furthermore	B-ADVP	RB	O	27	VMOD	O
O	O	O	1034	1035	,	,	O	,	O	27	P	O
O	O	O	1036	1039	the	the	B-NP	DT	O	8	NMOD	O
O	O	O	1040	1054	phosphorylated	phosphorylate	I-NP	VBN	O	8	NMOD	O
T10	B-Protein	B-Protein	1055	1056	I	I	I-NP	NN	B-protein	8	NMOD	B-protein
T10	I-Protein	I-Protein	1057	1062	kappa	kappa	I-NP	NN	I-protein	8	NMOD	I-protein
T10	I-Protein	I-Protein	1063	1064	B	B	I-NP	NN	I-protein	8	NMOD	I-protein
T10	I-Protein	I-Protein	1065	1070	alpha	alpha	I-NP	NN	I-protein	18	NMOD	I-protein
O	O	O	1071	1075	from	from	B-PP	IN	O	8	NMOD	O
O	O	O	1076	1085	calyculin	calyculin	B-NP	NN	B-protein	11	NMOD	B-protein
O	O	O	1086	1087	A	A	I-NP	NN	I-protein	14	NMOD	I-protein
O	O	O	1087	1088	-	-	B-NP	HYPH	O	14	NMOD	O
O	O	O	1088	1095	treated	treat	I-NP	VBN	B-cell_type	14	NMOD	B-cell_type
O	O	O	1096	1101	cells	cell	I-NP	NNS	I-cell_type	9	PMOD	I-cell_type
O	O	O	1101	1102	,	,	O	,	O	18	P	O
O	O	O	1103	1106	but	but	B-CONJP	CC	O	18	NMOD	O
O	O	O	1107	1110	not	not	I-CONJP	RB	O	16	DEP	O
O	O	O	1111	1115	that	that	B-NP	DT	O	27	SUB	O
O	O	O	1116	1120	from	from	B-PP	IN	O	18	NMOD	O
T11	B-Protein	B-Protein	1121	1124	TNF	TNF	B-NP	NN	B-protein	25	NMOD	B-protein
T11	I-Protein	I-Protein	1124	1125	-	-	B-NP	HYPH	O	25	NMOD	O
T11	I-Protein	I-Protein	1125	1130	alpha	alpha	I-NP	SYM	B-cell_line	25	NMOD	B-cell_line
O	O	O	1130	1131	-	-	I-NP	HYPH	I-cell_line	25	NMOD	I-cell_line
O	O	O	1131	1141	stimulated	stimulate	I-NP	VBN	I-cell_line	25	NMOD	I-cell_line
O	O	O	1142	1147	cells	cell	I-NP	NNS	I-cell_line	19	PMOD	I-cell_line
O	O	O	1147	1148	,	,	O	,	O	18	P	O
O	O	O	1149	1151	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	1152	1161	sensitive	sensitive	B-ADJP	JJ	O	33	AMOD	O
O	O	O	1162	1164	to	to	B-PP	TO	O	33	AMOD	O
O	O	O	1165	1167	PP	PP	B-NP	NN	B-protein	32	NMOD	B-protein
O	O	O	1167	1168	-	-	B-NP	HYPH	I-protein	32	NMOD	I-protein
O	O	O	1168	1170	2A	2A	I-NP	NN	I-protein	29	PMOD	I-protein
O	O	O	1171	1173	in	in	B-ADVP	FW	O	27	PRD	O
O	O	O	1174	1179	vitro	vitro	I-ADVP	FW	O	33	AMOD	O
O	O	O	1179	1180	,	,	O	,	O	27	P	O
O	O	O	1181	1191	suggesting	suggest	B-VP	VBG	O	27	VMOD	O
O	O	O	1192	1195	the	the	B-NP	DT	O	38	NMOD	O
O	O	O	1196	1205	existence	existence	I-NP	NN	O	36	OBJ	O
O	O	O	1206	1208	of	of	B-PP	IN	O	38	NMOD	O
O	O	O	1209	1220	fundamental	fundamental	B-NP	JJ	O	41	NMOD	O
O	O	O	1221	1232	differences	difference	I-NP	NNS	O	39	PMOD	O
O	O	O	1233	1235	in	in	B-PP	IN	O	41	NMOD	O
O	O	O	1236	1239	the	the	B-NP	DT	O	44	NMOD	O
O	O	O	1240	1255	phosphorylation	phosphorylation	I-NP	NN	O	42	PMOD	O
O	O	O	1256	1258	of	of	B-PP	IN	O	44	NMOD	O
T12	B-Protein	B-Protein	1259	1260	I	I	B-NP	NN	B-protein	49	NMOD	B-protein
T12	I-Protein	I-Protein	1261	1266	kappa	kappa	I-NP	NN	I-protein	49	NMOD	I-protein
T12	I-Protein	I-Protein	1267	1268	B	B	I-NP	NN	I-protein	49	NMOD	I-protein
T12	I-Protein	I-Protein	1269	1274	alpha	alpha	I-NP	NN	I-protein	45	PMOD	I-protein
O	O	O	1275	1282	induced	induce	B-VP	VBN	O	49	NMOD	O
O	O	O	1283	1285	by	by	B-PP	IN	O	50	VMOD	O
O	O	O	1286	1289	the	the	B-NP	DT	O	59	NMOD	O
O	O	O	1290	1293	two	two	I-NP	CD	O	59	NMOD	O
O	O	O	1294	1303	different	different	I-NP	JJ	O	59	NMOD	O
T25	B-Entity	B-Entity	1304	1306	NF	NF	I-NP	NN	B-protein	59	NMOD	B-protein
T25	I-Entity	I-Entity	1306	1307	-	-	B-NP	HYPH	I-protein	59	P	I-protein
T25	I-Entity	I-Entity	1307	1312	kappa	kappa	I-NP	NN	I-protein	59	NMOD	I-protein
T25	I-Entity	I-Entity	1313	1314	B	B	I-NP	NN	I-protein	59	NMOD	I-protein
O	O	O	1315	1323	inducers	inducer	I-NP	NNS	O	51	PMOD	O
O	O	O	1323	1324	.	.	O	.	O	27	P	O

O	O	O	1325	1332	However	However	B-ADVP	RB	O	19	VMOD	O
O	O	O	1332	1333	,	,	O	,	O	19	P	O
O	O	O	1334	1343	induction	induction	B-NP	NN	O	19	SUB	O
O	O	O	1344	1346	of	of	B-PP	IN	O	3	NMOD	O
T13	B-Protein	B-Protein	1347	1348	I	I	B-NP	NN	B-protein	8	NMOD	B-protein
T13	I-Protein	I-Protein	1349	1354	kappa	kappa	I-NP	NN	I-protein	8	NMOD	I-protein
T13	I-Protein	I-Protein	1355	1356	B	B	I-NP	NN	I-protein	8	NMOD	I-protein
T13	I-Protein	I-Protein	1357	1362	alpha	alpha	I-NP	NN	I-protein	9	NMOD	I-protein
O	O	O	1363	1378	phosphorylation	phosphorylation	I-NP	NN	O	4	PMOD	O
O	O	O	1379	1381	by	by	B-PP	IN	O	3	NMOD	O
O	O	O	1382	1386	both	both	O	CC	O	18	NMOD	O
T14	B-Protein	B-Protein	1387	1390	TNF	TNF	B-NP	NN	B-protein	14	NMOD	B-protein
T14	I-Protein	I-Protein	1390	1391	-	-	O	HYPH	O	14	P	O
T14	I-Protein	I-Protein	1391	1396	alpha	alpha	B-NP	SYM	O	18	NMOD	O
O	O	O	1397	1400	and	and	O	CC	O	18	NMOD	O
O	O	O	1401	1404	the	the	B-NP	DT	O	18	NMOD	O
O	O	O	1405	1416	phosphatase	phosphatase	I-NP	NN	B-protein	18	NMOD	B-protein
O	O	O	1417	1427	inhibitors	inhibitor	I-NP	NNS	O	10	PMOD	O
O	O	O	1428	1430	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	1431	1441	associated	associate	I-VP	VBN	O	19	VC	O
O	O	O	1442	1446	with	with	B-PP	IN	O	20	VMOD	O
O	O	O	1447	1450	the	the	B-NP	DT	O	24	NMOD	O
O	O	O	1451	1461	subsequent	subsequent	I-NP	JJ	O	24	NMOD	O
O	O	O	1462	1473	degradation	degradation	I-NP	NN	O	21	PMOD	O
O	O	O	1474	1476	of	of	B-PP	IN	O	24	NMOD	O
T15	B-Protein	B-Protein	1477	1478	I	I	B-NP	NN	B-protein	29	NMOD	B-protein
T15	I-Protein	I-Protein	1479	1484	kappa	kappa	I-NP	NN	I-protein	29	NMOD	I-protein
T15	I-Protein	I-Protein	1485	1486	B	B	I-NP	NN	I-protein	29	NMOD	I-protein
T15	I-Protein	I-Protein	1487	1492	alpha	alpha	I-NP	NN	I-protein	25	PMOD	I-protein
O	O	O	1492	1493	.	.	O	.	O	19	P	O

O	O	O	1494	1496	We	We	B-NP	PRP	O	3	SUB	O
O	O	O	1497	1504	further	further	B-ADVP	RB	O	3	VMOD	O
O	O	O	1505	1516	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT	O
O	O	O	1517	1521	that	that	B-SBAR	IN	O	3	VMOD	O
T16	B-Protein	B-Protein	1522	1525	TNF	TNF	B-NP	NN	B-protein	18	NMOD	B-protein
T16	I-Protein	I-Protein	1525	1526	-	-	O	HYPH	O	18	NMOD	O
T16	I-Protein	I-Protein	1526	1531	alpha	alpha	O	SYM	O	18	NMOD	O
O	O	O	1531	1532	-	-	O	HYPH	O	18	NMOD	O
O	O	O	1533	1536	and	and	O	CC	O	18	NMOD	O
O	O	O	1537	1546	calyculin	calyculin	B-NP	NN	O	11	NMOD	O
O	O	O	1547	1548	A	A	I-NP	NN	O	18	NMOD	O
O	O	O	1548	1549	-	-	B-NP	HYPH	O	11	P	O
O	O	O	1549	1556	induced	induce	I-NP	VBN	O	18	NMOD	O
T17	B-Protein	B-Protein	1557	1558	I	I	I-NP	NN	B-protein	18	NMOD	B-protein
T17	I-Protein	I-Protein	1559	1564	kappa	kappa	I-NP	NN	I-protein	18	NMOD	I-protein
T17	I-Protein	I-Protein	1565	1566	B	B	I-NP	NN	I-protein	18	NMOD	I-protein
T17	I-Protein	I-Protein	1567	1572	alpha	alpha	I-NP	NN	I-protein	18	NMOD	I-protein
O	O	O	1573	1584	degradation	degradation	I-NP	NN	O	19	SUB	O
O	O	O	1585	1593	exhibits	exhibit	B-VP	VBZ	O	4	SBAR	O
O	O	O	1594	1601	similar	similar	B-ADJP	JJ	O	23	AMOD	O
O	O	O	1602	1605	but	but	O	CC	O	23	AMOD	O
O	O	O	1606	1609	not	not	O	RB	O	21	DEP	O
O	O	O	1610	1619	identical	identical	B-NP	JJ	O	24	NMOD	O
O	O	O	1620	1633	sensitivities	sensitivity	I-NP	NNS	O	19	OBJ	O
O	O	O	1634	1636	to	to	B-PP	TO	O	24	NMOD	O
O	O	O	1637	1638	a	a	B-NP	DT	O	28	NMOD	O
O	O	O	1639	1649	proteasome	proteasome	I-NP	NN	B-protein	28	NMOD	B-protein
O	O	O	1650	1659	inhibitor	inhibitor	I-NP	NN	O	25	PMOD	O
O	O	O	1659	1660	.	.	O	.	O	3	P	O

O	O	O	1661	1669	Together	Together	B-ADVP	RB	O	5	VMOD	O
O	O	O	1669	1670	,	,	O	,	O	5	P	O
O	O	O	1671	1676	these	these	B-NP	DT	O	4	NMOD	O
O	O	O	1677	1684	results	result	I-NP	NNS	O	5	SUB	O
O	O	O	1685	1692	suggest	suggest	B-VP	VBP	O	0	ROOT	O
O	O	O	1693	1697	that	that	B-SBAR	IN	O	5	VMOD	O
O	O	O	1698	1713	phosphorylation	phosphorylation	B-NP	NN	O	32	SUB	O
O	O	O	1714	1716	of	of	B-PP	IN	O	7	NMOD	O
T18	B-Protein	B-Protein	1717	1718	I	I	B-NP	NN	B-protein	12	NMOD	B-protein
T18	I-Protein	I-Protein	1719	1724	kappa	kappa	I-NP	NN	I-protein	12	NMOD	I-protein
T18	I-Protein	I-Protein	1725	1726	B	B	I-NP	NN	I-protein	12	NMOD	I-protein
T18	I-Protein	I-Protein	1727	1732	alpha	alpha	I-NP	NN	I-protein	8	PMOD	I-protein
O	O	O	1732	1733	,	,	O	,	O	7	P	O
O	O	O	1734	1742	mediated	mediate	B-VP	VBN	O	7	NMOD	O
O	O	O	1743	1750	through	through	B-PP	IN	O	14	VMOD	O
O	O	O	1751	1755	both	both	O	CC	O	30	NMOD	O
O	O	O	1756	1759	the	the	B-NP	DT	O	30	NMOD	O
T19	B-Protein	B-Protein	1760	1763	TNF	TNF	I-NP	NN	B-protein	20	NMOD	B-protein
T19	I-Protein	I-Protein	1763	1764	-	-	O	HYPH	O	20	P	O
T19	I-Protein	I-Protein	1764	1769	alpha	alpha	O	SYM	O	30	NMOD	O
O	O	O	1769	1770	-	-	O	HYPH	O	30	P	O
O	O	O	1770	1779	inducible	inducible	B-ADJP	JJ	O	30	NMOD	O
O	O	O	1780	1783	and	and	O	CC	O	30	NMOD	O
O	O	O	1784	1787	the	the	B-NP	DT	O	27	NMOD	O
O	O	O	1788	1790	PP	PP	I-NP	NN	B-protein	27	NMOD	B-protein
O	O	O	1790	1791	-	-	B-NP	HYPH	I-protein	27	P	I-protein
O	O	O	1791	1793	2A	2A	I-NP	NN	I-protein	30	NMOD	I-protein
O	O	O	1793	1794	-	-	O	HYPH	I-protein	30	NMOD	I-protein
O	O	O	1794	1802	opposing	oppose	B-VP	VBG	I-protein	30	NMOD	I-protein
O	O	O	1803	1810	kinases	kinase	B-NP	NNS	I-protein	15	PMOD	I-protein
O	O	O	1810	1811	,	,	O	,	O	7	P	O
O	O	O	1812	1815	may	may	B-VP	MD	O	6	SBAR	O
O	O	O	1816	1821	serve	serve	I-VP	VB	O	32	VC	O
O	O	O	1822	1824	to	to	B-PP	TO	O	33	VMOD	O
O	O	O	1825	1831	target	target	B-NP	NN	O	39	NMOD	O
T20	B-Protein	B-Protein	1832	1833	I	I	I-NP	NN	B-protein	39	NMOD	B-protein
T20	I-Protein	I-Protein	1834	1839	kappa	kappa	I-NP	NN	I-protein	39	NMOD	I-protein
T20	I-Protein	I-Protein	1840	1841	B	B	I-NP	NN	I-protein	39	NMOD	I-protein
T20	I-Protein	I-Protein	1842	1847	alpha	alpha	I-NP	NN	I-protein	44	NMOD	I-protein
O	O	O	1848	1851	for	for	B-PP	IN	O	39	NMOD	O
T26	B-Entity	B-Entity	1852	1862	proteasome	proteasome	B-NP	NN	B-protein	40	PMOD	B-protein
O	O	O	1862	1863	-	-	B-NP	HYPH	O	44	NMOD	O
O	O	O	1863	1871	mediated	mediate	I-NP	VBN	O	44	NMOD	O
O	O	O	1872	1883	degradation	degradation	I-NP	NN	O	34	PMOD	O
O	O	O	1883	1884	.	.	O	.	O	5	P	O
